Mandate

Vinge has represented ABG Sundal Collier in connection with the founding of a new investment company focused on properties in Sweden and Finland.

Vinge has represented ABG Sundal Collier in connection with the founding of ABG Sundal Collier Fastena AB together with the other three co-founders Andreas Birgersson, Per Nisses and Philip Söderqvist.

ABG Sundal Collier Fastena is an investment company focused on properties in Sweden and Finland, which intends to acquire and manage properties on behalf of investors.

Vinge's team consisted mainly of Kristoffer Franzkeit, Niklas Törnell, Maria Schultzberg (tax), and Martin Svanberg (regulatory issues).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025